Fig. 2
From: Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
IC50s in OCCC cell lines. (A) Summary of IC50 values in 3 sets of ARID1A isogenic cell lines (JHOC5, ES2, OVCA429; KD: ARID1A shRNA knockdown; WTC: wildtype control). Solid shapes, WTC; Open shapes, KD. (B) Summary of IC50 values in OCCC cell lines (WT: JHOC5, ES2, OVCA429, RMG1; Mut: OVTOKO, KOC7C). Values of IC50 were calculated from dose curves (Supplementary. Figure 2). Circles, WT; Triangles, Mut; *: p < 0.05